Desert Regional Medical Center in Palm Springs, Calif., will assume management of its comprehensive cancer center and terminate its management agreement with Aptium, a subsidiary of pharmaceutical company AstraZeneca, according to a Desert Sun report.
The management transition is prompted by AstraZeneca’s decision to sell Aptium, according to the report. Aptium had managed the center for approximately 20 years.
While the termination agreement is not finalized, AstraZeneca and Desert Regional’s operator, Tenet Healthcare, consider the deal as certain, according to the report.
Related Articles on Hospital Cancer Programs:
NY’s Hudson Valley Hospital Unveils $12M Cancer Center
Illinois’ FHN Memorial Hospital Expanding Cancer Center
Illinois’ Advocate Lutheran Opens $6M CyberKnife Cancer Center
At the Becker's 11th Annual IT + Revenue Cycle Conference: The Future of AI & Digital Health, taking place September 14–17 in Chicago, healthcare executives and digital leaders from across the country will come together to explore how AI, interoperability, cybersecurity, and revenue cycle innovation are transforming care delivery, strengthening financial performance, and driving the next era of digital health. Apply for complimentary registration now.
